For instance, inhibition of both the mTOR and MAPK (ERK) pathways using rapamycin and the MEK1/2 inhibitor PD325901 was identified as a means of robustly blocking effector CD4+ T cell proliferation in a mouse model of arthritis (84). Here, MTOR is linked to arthritic joint disease.